Other reports

Consolidated Statement of Comprehensive Income

€ million

 

Note

 

2023

 

2022

Profit after tax

 

 

 

2,834

 

3,339

Items of other comprehensive income that will not be reclassified to profit or loss in subsequent periods

 

 

 

 

 

 

Net defined benefit liability

 

33

 

 

 

 

Changes in remeasurement

 

 

 

-236

 

1,440

Tax effect

 

 

 

48

 

-300

Changes recognized in equity

 

 

 

-187

 

1,140

Equity instruments

 

34

 

 

 

 

Fair value adjustments

 

 

 

158

 

-34

Tax effect

 

 

 

2

 

3

Changes recognized in equity

 

 

 

160

 

-31

 

 

 

 

-28

 

1,109

Items of other comprehensive income that may be reclassified to profit or loss in subsequent periods

 

 

 

 

 

 

Cash flow hedge reserve

 

39

 

 

 

 

Fair value adjustments

 

 

 

98

 

-98

Reclassification to profit or loss

 

 

 

-95

 

194

Reclassification to assets

 

 

 

 

Tax effect

 

 

 

-5

 

-5

Changes recognized in equity

 

 

 

-2

 

91

Cost of cash flow hedge reserve

 

39

 

 

 

 

Fair value adjustments

 

 

 

-17

 

-15

Reclassification to profit or loss

 

 

 

22

 

16

Reclassification to assets

 

 

 

 

Tax effect

 

 

 

 

10

Changes recognized in equity

 

 

 

5

 

11

Currency translation difference

 

 

 

 

 

 

Changes taken directly to equity

 

 

 

-1,003

 

1,228

Reclassification to profit or loss

 

 

 

-15

 

-71

Changes recognized in equity

 

 

 

-1,018

 

1,157

 

 

 

 

-1,015

 

1,259

Other comprehensive income

 

 

 

-1,043

 

2,368

Comprehensive income

 

 

 

1,791

 

5,708

thereof: attributable to shareholders of Merck KGaA, Darmstadt, Germany

 

 

 

1,783

 

5,696

thereof: attributable to non-controlling interests

 

34

 

8

 

12

Share this page: